Immunomodulators Market Analysis by Product (Immunostimulants, Immunosuppressants), by Application (Respiratory, Oncology, HIV), and by Region - Forecast to 2029

Request Sample Page

The global immunomodulators market size is estimated to be USD 1768.2 billion in 2021 and is expected to witness a CAGR of 6.81% during the forecast period. Escalating adoption of monoclonal antibodies for the treatment of chronic diseases is a key driver for the growth of the market. Additionally, the rise in cases of chronic diseases mainly cancer, introduction of novel treatments in the market, and incidence of strong pipeline portfolio are some of the other drivers propelling the market growth. Nevertheless, the increasing number of patent expiration, rising generic & biosimilars competition, and stringent regulatory framework are expected to restrain the global market growth.

Global Immunomodulators Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is categorized into immunosuppressants and immunostimulants. In 2021, the immunosuppressants segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the availability of an extensive variety of therapeutics, such as cyclosporine, monoclonal antibodies, azathioprine, and corticosteroids worldwide. The immunostimulants segment is anticipated to grow at a profitable CAGR during the forecast period, due to the launch of novel products and technologies are the key factors driving the market worldwide.

By Application

Based on application, the market is categorized into respiratory, oncology, HIV, and others. In 2021, the oncology segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the untouched opportunities along with the development of new drug enterprises because of the unmet requirements worldwide. The respiratory segment is anticipated to grow at a profitable CAGR during the forecast period, this is due to new product launches for several symptoms that will be generating future market growth opportunities in the global market.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of a large population section affected by diseases, the existence of major players in the market, growth in initiatives from the government, accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the fewer regulations regarding new product launches, growing government and corporate investment in the healthcare sector, and availability of raw materials at economic costs, which are the major factors in this region.

Competitor Insights

Some of the key players in the immunomodulators market are F. Hoffmann-La Roche Ltd. (Switzerland); Amgen, Inc. (U.S.); Abbott Laboratories (U.S.); Johnson & Johnson (U.S.); Novartis AG (Switzerland); Eli Lilly and Company (U.S.); Bristol-Myers Squibb Company (U.S.); Merck & Co., Inc. (U.S.); Biogen Inc. (U.S.); and Inc. (U.S.). The leading players operating in the immunomodulators industry are adopting various strategies including R&D investments, adoption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The immunomodulators market report is categorized into the following segments and subsegments:

Immunomodulators Market, By Product (Revenue, USD Billion, 2021 – 2029)

  • Immunosuppressants
    • Antibodies
    • Calcineurin inhibitors
    • Glucocorticoid
    • Antimetabolites
    • Others
  • Immunostimulants
    • Vaccines
    • Antibodies
    • Others

Immunomodulators Market, By Application (Revenue, USD Billion, 2021 – 2029)

  • Respiratory
  • Oncology
  • HIV
  • Others

Immunomodulators Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Immunomodulators Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Immunomodulators Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Immunomodulators
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Immunomodulators Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product
    1. Immunostimulants
      1. Immunostimulants Market Forecast, 2021-2029 (USD Million)
    2. Immunosuppressants
      1. Immunosuppressants Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Respiratory
      1. Respiratory Market Forecast, 2021-2029 (USD Million)
    2. HIV
      1. HIV Market Forecast, 2021-2029 (USD Million)
    3. Oncology
      1. Oncology Market Forecast, 2021-2029 (USD Million)
    4. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Immunomodulators Market
    1. North America Immunomodulators Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. S. Immunomodulators Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Canada Immunomodulators Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Europe Immunomodulators Market
    1. Europe Immunomodulators Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Germany Immunomodulators Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. UK Immunomodulators Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. France Immunomodulators Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Spain Immunomodulators Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              2. Italy Immunomodulators Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Europe Immunomodulators Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Asia Pacific Immunomodulators Market
    1. Asia Pacific Immunomodulators Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Japan Immunomodulators Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. China Immunomodulators Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. India Immunomodulators Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. South Korea Immunomodulators Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Immunomodulators Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Immunomodulators Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Latin America Immunomodulators Market
    1. Latin America Immunomodulators Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. Brazil Immunomodulators Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. Mexico Immunomodulators Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Argentina Immunomodulators Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            2. Rest of Latin America Immunomodulators Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. MEA Immunomodulators Market
    1. MEA Immunomodulators Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
      2. GCC Immunomodulators Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        2. South Africa Immunomodulators Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          2. Rest of MEA Immunomodulators Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Amgen (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. AstraZeneca (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Hoffman La-Roche (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Bayer AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Bristol-Myers Squibb (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Eli Lilly and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Janssen Global Services, LLC (Belgium)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Merck (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Merck (U.S.)
      1. Company Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    10. Novartis (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Pfizer (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports